Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer
- 1 March 2002
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 52 (3), 739-747
- https://doi.org/10.1016/s0360-3016(01)02683-9
Abstract
No abstract availableThis publication has 29 references indexed in Scilit:
- Avoidance of treatment interruption: an unrecognized benefit of accelerated radiotherapy in oropharyngeal carcinomas?International Journal of Radiation Oncology*Biology*Physics, 1999
- Hyperfractionated Irradiation with or without Concurrent Chemotherapy for Locally Advanced Head and Neck CancerThe New England Journal of Medicine, 1998
- A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary resultsHead & Neck, 1997
- 59: Protection of salivary glands by amifostine in patients treated with high dose radioiodineEuropean Journal of Cancer, 1997
- Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsCancer, 1997
- Povidone-Iodine to Prevent Mucositis in Patients during Antineoplastic RadiochemotherapyDermatology, 1997
- The Effect of Overall Treatment Time of Radiation Therapy on Local Control of T1‐Stage Squamous Call Carcinoma of the GlottisThe Laryngoscope, 1996
- Five-Year Update of a Randomized Trial of Alternating Radiotherapy and Chemotherapy Compared With Radiotherapy Alone in Treatment of Unresectable Squamous Cell Carcinoma of the Head and NeckJNCI Journal of the National Cancer Institute, 1996
- Influence of Late Side-Effects Upon Daily Life After Radiotherapy for Laryngeal and Pharyngeal CancerActa Oncologica, 1994
- Pharmacokinetics of WR-2721Pharmacology & Therapeutics, 1988